Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
KEGG_2021_Human,Transcriptional misregulation in cancer,19/192,0.0002603263778067943,0.0700277956300276,0,0,2.6792055728471915,22.11302256836593,BCL11B;MAX;TFE3;DOT1L;ASPSCR1;PBX3;TMPRSS2;MLLT3;KLF3;PML;DDB2;CCNA2;RXRB;NCOR1;EWSR1;WT1;ID2;ATM;PROM1
KEGG_2021_Human,Mitophagy,8/68,0.0055773198114316,0.7501495146375569,0,0,3.226464391066161,16.742275170679,BECN1;MAPK9;CALCOCO2;TFE3;MFN1;FOXO3;TBC1D17;HIF1A
KEGG_2021_Human,Notch signaling pathway,7/59,0.0088738163069748,0.7956855288587418,0,0,3.2547348484848486,15.377484064166929,JAG2;TLE2;KAT2A;TLE1;CTBP1;HES1;DTX3
KEGG_2021_Human,Hedgehog signaling pathway,6/56,0.023776509839993,0.9999934106986268,0,0,2.898007566204288,10.835815961029244,GSK3B;GRK3;KIF3A;CSNK1A1;SMURF1;CSNK1D
KEGG_2021_Human,Non-small cell lung cancer,7/72,0.0246483100141124,0.9999934106986268,0,0,2.602020202020202,9.635402947192572,PRKCG;RXRB;STAT3;TGFA;FOXO3;STK4;DDB2
KEGG_2021_Human,Circadian rhythm,4/31,0.0337908638307761,0.9999934106986268,0,0,3.5730724435126957,12.104014487143717,PER1;CRY2;CSNK1D;NR1D1
KEGG_2021_Human,Thyroid hormone signaling pathway,9/121,0.053465165798212,0.9999934106986268,0,0,1.9416930379746835,5.686684833359246,PRKCG;RXRB;RCAN1;GSK3B;KAT2A;NCOR1;HDAC3;PLCD3;HIF1A
KEGG_2021_Human,Terpenoid backbone biosynthesis,3/22,0.0556137036302874,0.9999934106986268,0,0,3.804945781539276,10.993727405119246,HMGCS2;RCE1;DHDDS
KEGG_2021_Human,Pathways in cancer,29/531,0.0558339085616868,0.9999934106986268,0,0,1.4028845656335696,4.047846529809013,GSK3B;CAMK2D;CTBP1;MAX;TGFA;LAMC2;STK4;HIF1A;RASGRP4;PLD2;RXRB;MAPK9;WNT11;PIM1;HES1;IL12RB1;PRKCG;JAG2;DAPK2;PLEKHG5;TXNRD1;STAT3;PML;DDB2;CCNA2;IL7;COL4A4;GNB5;IFNAR1
KEGG_2021_Human,Synthesis and degradation of ketone bodies,2/10,0.0579820962127308,0.9999934106986268,0,0,6.02038895859473,17.14378603916348,BDH2;HMGCS2
KEGG_2021_Human,Hippo signaling pathway,11/163,0.0627420065550043,0.9999934106986268,0,0,1.749423924659364,4.843672171982708,SOX2;TEAD4;GSK3B;PATJ;WNT11;DLG5;ID2;PPP2R2D;CSNK1D;SCRIB;LLGL1
KEGG_2021_Human,Tight junction,11/169,0.0767680318931659,0.9999934106986268,0,0,1.6824600012850992,4.318819263214002,MAPK9;PATJ;CLDN4;MYL6;CLDN7;MARVELD3;PPP2R2D;SCRIB;WHAMM;SYNPO;LLGL1
KEGG_2021_Human,Thyroid hormone synthesis,6/75,0.0790369893564017,0.9999934106986268,0,0,2.097922035199298,5.324189023659078,PRKCG;TTR;DUOXA2;ASGR1;DUOX2;ASGR2
KEGG_2021_Human,Pancreatic cancer,6/76,0.0830715654389778,0.9999934106986268,0,0,2.067843631778058,5.1449041555663735,MAPK9;STAT3;TGFA;DDB2;ARHGEF6;PLD2
KEGG_2021_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,3/26,0.0836252593483379,0.9999934106986268,0,0,3.142560629233122,7.797980300041985,DPM2;PIGB;PIGA
KEGG_2021_Human,Glycerophospholipid metabolism,7/98,0.0972410984342427,0.9999934106986268,0,0,1.856060606060606,4.325664009115818,CHKA;PNPLA6;PLA2G6;CDIPT;CRLS1;PLB1;PLD2
KEGG_2021_Human,Butanoate metabolism,3/28,0.0994820308333711,0.9999934106986268,0,0,2.890854271356784,6.671450599117634,BDH2;ACSM1;HMGCS2
KEGG_2021_Human,Glycosphingolipid biosynthesis,4/45,0.104139150593961,0.9999934106986268,0,0,2.351280871299279,5.3186614918476005,B4GALT3;ST8SIA1;A4GALT;B4GALT4
KEGG_2021_Human,Ubiquitin mediated proteolysis,9/140,0.1085883805795646,0.9999934106986268,0,0,1.6584211034882597,3.6820113926266114,SMURF1;FBXO2;UBE2D3;CBLB;BIRC6;RNF7;MID1;PML;DDB2
KEGG_2021_Human,Proteasome,4/46,0.110657347240237,0.9999934106986268,0,0,2.2951781970649896,5.052414356243582,PSMC5;PSMD4;PSMC3;PSME2
KEGG_2021_Human,Human papillomavirus infection,18/331,0.1158501930102108,0.9999934106986268,0,0,1.3907949585400874,2.997799232514593,HES7;GSK3B;PATJ;ATP6V1G2;VWF;CSNK1A1;SCRIB;LAMC2;CCNA2;WNT11;IRF3;COL4A4;PPP2R2D;ATM;HES1;ATP6V0E2;LLGL1;IFNAR1
KEGG_2021_Human,ErbB signaling pathway,6/85,0.124314827599475,0.9999934106986268,0,0,1.8314045365300813,3.818364909325215,PRKCG;GSK3B;MAPK9;CAMK2D;TGFA;CBLB
KEGG_2021_Human,Wnt signaling pathway,10/166,0.1289209841757457,0.9999934106986268,0,0,1.5473172792564427,3.16976545892324,PRKCG;GSK3B;MAPK9;TLE2;CAMK2D;TLE1;WNT11;CTBP1;CSNK1A1;NLK
KEGG_2021_Human,Ether lipid metabolism,4/49,0.1312517835380505,0.9999934106986268,0,0,2.141830887491265,4.349282737233281,ENPP6;PLA2G6;PLB1;PLD2
KEGG_2021_Human,Adipocytokine signaling pathway,5/69,0.1413545332534841,0.9999934106986268,0,0,1.8829699307304784,3.684000775880504,RXRB;MAPK9;STAT3;LEPR;CAMKK2
KEGG_2021_Human,Fructose and mannose metabolism,3/33,0.1436872154259992,0.9999934106986268,0,0,2.408417085427136,4.672609622677708,PFKFB4;SORD;HK2
KEGG_2021_Human,HIF-1 signaling pathway,7/109,0.1460916450732024,0.9999934106986268,0,0,1.6549440483264013,3.1833198760732757,PRKCG;ANGPT4;CAMK2D;STAT3;HIF1A;EIF4E;HK2
KEGG_2021_Human,Primary bile acid biosynthesis,2/17,0.1461906583389781,0.9999934106986268,0,0,3.209703053115851,6.171757070382955,ACOT8;CYP7B1
KEGG_2021_Human,Prolactin signaling pathway,5/70,0.1475690304937882,0.9999934106986268,0,0,1.853904282115869,3.547370221838266,GSK3B;MAPK9;STAT3;FOXO3;SOCS7
KEGG_2021_Human,Adherens junction,5/71,0.1538975772135964,0.9999934106986268,0,0,1.8257194107320047,3.416775419224888,CTNND1;LMO7;SORBS1;NLK;BAIAP2
KEGG_2021_Human,p53 signaling pathway,5/73,0.1668830605971806,0.9999934106986268,0,0,1.7718365683805009,3.17240595338829,PIDD1;SESN3;ATM;MDM4;DDB2
KEGG_2021_Human,Fanconi anemia pathway,4/54,0.1686959522840863,0.9999934106986268,0,0,1.9271446540880504,3.429657019604935,TOP3A;POLI;PMS2;HES1
KEGG_2021_Human,Glutamatergic synapse,7/114,0.1715188681171544,0.9999934106986268,0,0,1.5771972057018786,2.780696460276415,PRKCG;GRK3;HOMER2;CACNA1A;GNB5;SHANK3;PLD2
KEGG_2021_Human,Insulin signaling pathway,8/137,0.1826850762181354,0.9999934106986268,0,0,1.4952714158312015,2.541948702435676,GSK3B;MAPK9;PHKG1;PHKG2;CBLB;SORBS1;EIF4E;HK2
KEGG_2021_Human,"Neomycin, kanamycin and gentamicin biosynthesis",1/5,0.1844315223508651,0.9999934106986268,0,0,6.014097744360902,10.166694134908443,HK2
KEGG_2021_Human,Epstein-Barr virus infection,11/202,0.1860788008328145,0.9999934106986268,0,0,1.389361362851144,2.336329275416643,CCNA2;CXCL10;MAPK9;PSMC5;PSMD4;PSMC3;IRF3;STAT3;HES1;DDB2;IFNAR1
KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,6/98,0.1978832934213829,0.9999934106986268,0,0,1.5715499753275948,2.546033303990616,PRKCG;MAPK9;CAMK2D;TRPV3;PLA2G6;NGF
KEGG_2021_Human,JAK-STAT signaling pathway,9/162,0.2006137643124961,0.9999934106986268,0,0,1.4183172002978406,2.278347576596418,IL7;FHL1;STAT3;LEPR;PIM1;IL12RB1;SOCS7;PTPN2;IFNAR1
KEGG_2021_Human,Pantothenate and CoA biosynthesis,2/21,0.2039694204446872,0.9999934106986268,0,0,2.5334477976622862,4.027637803954891,PANK2;PPCDC
KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,8/143,0.2134287235785042,0.9999934106986268,0,0,1.428365407126469,2.2060423089244128,SOX2;GSK3B;WNT11;ID2;PCGF2;STAT3;SKIL;NODAL
KEGG_2021_Human,Spinocerebellar ataxia,8/143,0.2134287235785042,0.9999934106986268,0,0,1.428365407126469,2.2060423089244128,PRKCG;BECN1;MAPK9;PSMC5;PSMD4;NFYA;PSMC3;CACNA1A
KEGG_2021_Human,Arginine biosynthesis,2/22,0.218804995301399,0.9999934106986268,0,0,2.406649937264743,3.657083582083921,ARG2;ACY1
KEGG_2021_Human,Mannose type O-glycan biosynthesis,2/23,0.2337269947066721,0.9999934106986268,0,0,2.2919280635717274,3.331550149080345,B4GALT3;LARGE2
KEGG_2021_Human,Mismatch repair,2/23,0.2337269947066721,0.9999934106986268,0,0,2.2919280635717274,3.331550149080345,EXO1;PMS2
KEGG_2021_Human,Lysine degradation,4/63,0.2436822167258711,0.9999934106986268,0,0,1.6324059268734676,2.304778082395242,SETD2;EHMT2;DOT1L;KMT5B
KEGG_2021_Human,Protein processing in endoplasmic reticulum,9/171,0.2454708376015287,0.9999934106986268,0,0,1.3388888888888888,1.8805727083616977,MAPK9;SEC24A;FBXO2;UBE2D3;SSR1;SEC24C;SEC31B;SEC31A;HERPUD1
KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",6/106,0.2495688425545064,0.9999934106986268,0,0,1.445220680958386,2.005995902983261,PRKCG;NR4A2;RXRB;JUND;PTH;PLD2
KEGG_2021_Human,Calcium signaling pathway,12/240,0.2533402972709348,0.9999934106986268,0,0,1.2688423727680065,1.7421480425638325,PRKCG;CAMK2D;P2RX4;PHKG1;SPHK1;PHKG2;CACNA1A;PLCD3;NGF;TPCN2;MYLK4;TRDN
KEGG_2021_Human,alpha-Linolenic acid metabolism,2/25,0.2637104116104324,0.9999934106986268,0,0,2.0924117614969178,2.7889833863914624,PLA2G6;PLB1
KEGG_2021_Human,FoxO signaling pathway,7/131,0.2698487423136997,0.9999934106986268,0,0,1.359756842619746,1.7811369089182123,MAPK9;HOMER2;STAT3;ATM;FOXO3;NLK;STK4
KEGG_2021_Human,Oxytocin signaling pathway,8/154,0.2742672604291291,0.9999934106986268,0,0,1.319986838231474,1.7076039366016982,PRKCG;CACNB2;RCAN1;MYL6;CAMK2D;PPP1R12C;MYLK4;CAMKK2
KEGG_2021_Human,Dopaminergic synapse,7/132,0.2760752529827768,0.9999934106986268,0,0,1.348808080808081,1.7360263253443806,PRKCG;GSK3B;MAPK9;CAMK2D;PPP2R2D;CACNA1A;GNB5
KEGG_2021_Human,Type II diabetes mellitus,3/46,0.2784902548872545,0.9999934106986268,0,0,1.6791515718125511,2.146580708562288,MAPK9;CACNA1A;HK2
KEGG_2021_Human,Acute myeloid leukemia,4/67,0.2791308636105852,0.9999934106986268,0,0,1.5284416491963662,1.9504055079320703,CCNA2;STAT3;PIM1;PML
KEGG_2021_Human,Shigellosis,12/246,0.2802415574879822,0.9999934106986268,0,0,1.2359169843286744,1.5722141267119831,GSK3B;BECN1;MAPK9;IRF3;FNBP1;CALCOCO2;UBE2D3;ATM;PLCD3;FOXO3;HK2;CYTH1
KEGG_2021_Human,Vascular smooth muscle contraction,7/133,0.2823382368345078,0.9999934106986268,0,0,1.338033108866442,1.692142909304999,NPPB;PRKCG;MYL6;RAMP3;PLA2G6;PPP1R12C;MYLK4
KEGG_2021_Human,Nucleotide excision repair,3/47,0.289476920246908,0.9999934106986268,0,0,1.640903380539059,2.034194623570225,ERCC2;ERCC5;DDB2
KEGG_2021_Human,Hepatitis C,8/157,0.2916528037989429,0.9999934106986268,0,0,1.2932062888705995,1.5934774247784862,CXCL10;GSK3B;CLDN4;IRF3;CLDN7;STAT3;PPP2R2D;IFNAR1
KEGG_2021_Human,Collecting duct acid secretion,2/27,0.2937021246731127,0.9999934106986268,0,0,1.9248180677540776,2.3582663213630326,ATP6V1G2;ATP6V0E2
KEGG_2021_Human,Renal cell carcinoma,4/69,0.2971548564253455,0.9999934106986268,0,0,1.48125786163522,1.7975091909074985,FLCN;TFE3;TGFA;HIF1A
KEGG_2021_Human,Morphine addiction,5/91,0.2987013526116755,0.9999934106986268,0,0,1.3996690293480172,1.69123552013089,PRKCG;GRK3;PDE2A;CACNA1A;GNB5
KEGG_2021_Human,Amino sugar and nucleotide sugar metabolism,3/48,0.3004941027710278,0.9999934106986268,0,0,1.604355108877722,1.9289597055189165,GNPDA2;HK2;GNE
KEGG_2021_Human,RIG-I-like receptor signaling pathway,4/70,0.3062206631423154,0.9999934106986268,0,0,1.4587383266628549,1.726342874230519,MAPK9;CXCL10;SIKE1;IRF3
KEGG_2021_Human,Small cell lung cancer,5/92,0.3065526624221247,0.9999934106986268,0,0,1.3835084976403489,1.6358130205177297,RXRB;MAX;COL4A4;LAMC2;DDB2
KEGG_2021_Human,Autophagy,7/137,0.3077138082512772,0.9999934106986268,0,0,1.2965909090909091,1.5281427547312612,RUBCN;BECN1;MAPK9;DAPK2;SMCR8;HIF1A;CAMKK2
KEGG_2021_Human,IL-17 signaling pathway,5/94,0.3223400325844665,0.9999934106986268,0,0,1.3522769082727195,1.5309779876851368,GSK3B;MAPK9;CXCL10;JUND;CCL17
KEGG_2021_Human,Arginine and proline metabolism,3/50,0.3225797561065039,0.9999934106986268,0,0,1.535924302362878,1.737752231904332,ARG2;P4HA2;ODC1
KEGG_2021_Human,Vibrio cholerae infection,3/50,0.3225797561065039,0.9999934106986268,0,0,1.535924302362878,1.737752231904332,ATP6V1G2;KDELR1;ATP6V0E2
KEGG_2021_Human,Linoleic acid metabolism,2/29,0.323517195786335,0.9999934106986268,0,0,1.7820530693805474,2.011052254574243,PLA2G6;PLB1
KEGG_2021_Human,Ras signaling pathway,11/232,0.3238586460705196,0.9999934106986268,0,0,1.1988653329352046,1.3516584848688875,PRKCG;MAPK9;ANGPT4;SYNGAP1;TGFA;GNB5;PLA2G6;STK4;NGF;RASGRP4;PLD2
KEGG_2021_Human,Sulfur metabolism,1/10,0.3348827921133522,0.9999934106986268,0,0,2.6722361459203565,2.9233586897414634,SQOR
KEGG_2021_Human,AMPK signaling pathway,6/120,0.3470450621307746,0.9999934106986268,0,0,1.2668082564545031,1.3406639954270092,CCNA2;PFKFB4;PPP2R2D;LEPR;FOXO3;CAMKK2
KEGG_2021_Human,Glioma,4/75,0.351859534308813,0.9999934106986268,0,0,1.3556559482682258,1.416014134306948,PRKCG;CAMK2D;TGFA;DDB2
KEGG_2021_Human,Choline metabolism in cancer,5/98,0.35414992050361,0.9999934106986268,0,0,1.2938436120365104,1.3430548907499575,PRKCG;MAPK9;CHKA;HIF1A;PLD2
KEGG_2021_Human,mRNA surveillance pathway,5/98,0.35414992050361,0.9999934106986268,0,0,1.2938436120365104,1.3430548907499575,PCF11;PPP2R2D;ACIN1;TARDBP;SRRM1
KEGG_2021_Human,Hepatocellular carcinoma,8/168,0.3572878062045581,0.9999934106986268,0,0,1.2036030341340076,1.238764662459305,PRKCG;GSK3B;WNT11;CSNK1A1;TXNRD1;TGFA;SMARCA2;DDB2
KEGG_2021_Human,Taurine and hypotaurine metabolism,1/11,0.3614674739416318,0.9999934106986268,0,0,2.4048872180451126,2.447172871130716,CSAD
KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,9/193,0.3660159251334687,0.9999934106986268,0,0,1.1774422124380848,1.1834217764554107,RCAN1;GSK3B;BECN1;MAPK9;IRF3;STAT3;GNB5;HIF1A;IFNAR1
KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,5/100,0.3701150127310074,0.9999934106986268,0,0,1.2664722259048125,1.25879927406999,MAPK9;COL4A4;STAT3;PIM1;PLCD3
KEGG_2021_Human,Synaptic vesicle cycle,4/78,0.3792975814579503,0.9999934106986268,0,0,1.3004929457759646,1.260742347126411,ATP6V1G2;CACNA1A;ATP6V0E2;STX1A
KEGG_2021_Human,SNARE interactions in vesicular transport,2/33,0.3820185151162972,0.9999934106986268,0,0,1.5517869429716276,1.4932631646884669,STX1A;VTI1B
KEGG_2021_Human,Longevity regulating pathway,5/102,0.3860835155711184,0.9999934106986268,0,0,1.240229556726999,1.1803284179555389,SESN3;EHMT2;FOXO3;EIF4E;CAMKK2
KEGG_2021_Human,Spliceosome,7/150,0.3924140910708021,0.9999934106986268,0,0,1.1779155188246098,1.1018665153683496,TCERG1;HNRNPM;SNRNP70;ACIN1;SRSF5;USP39;SRSF7
KEGG_2021_Human,MAPK signaling pathway,13/294,0.394058957734902,0.9999934106986268,0,0,1.11361640089466,1.0370605540552629,PRKCG;ANGPT4;JUND;MAX;TGFA;CACNA1A;NLK;STK4;NGF;RASGRP4;CACNB2;MAPK9;MAP3K6
KEGG_2021_Human,Toll-like receptor signaling pathway,5/104,0.4020292292749913,0.9999934106986268,0,0,1.2150471974149557,1.1071880450142115,CXCL10;MAPK9;IRF3;CCL3;IFNAR1
KEGG_2021_Human,Endometrial cancer,3/58,0.4102931993440706,0.9999934106986268,0,0,1.311968935587026,1.1688111551506255,GSK3B;FOXO3;DDB2
KEGG_2021_Human,Nicotinate and nicotinamide metabolism,2/35,0.4104659692826623,0.9999934106986268,0,0,1.4575871639861602,1.2979263517030897,SIRT2;SIRT3
KEGG_2021_Human,Non-homologous end-joining,1/13,0.411495217755799,0.9999934106986268,0,0,2.0038638262322475,1.7793466758017835,DNTT
KEGG_2021_Human,Th17 cell differentiation,5/107,0.4258505533183018,0.9999934106986268,0,0,1.1791253025139528,1.006580133310632,RXRB;MAPK9;STAT3;IL12RB1;HIF1A
KEGG_2021_Human,Ribosome biogenesis in eukaryotes,5/108,0.4337531940983641,0.9999934106986268,0,0,1.1676163458951847,0.9752860954755233,LSG1;REXO1;HEATR1;GAR1;IMP4
KEGG_2021_Human,Aldosterone-regulated sodium reabsorption,2/37,0.4382534621111668,0.9999934106986268,0,0,1.3741530740276036,1.133618372882936,SLC9A3R2;PRKCG
KEGG_2021_Human,Thyroid cancer,2/37,0.4382534621111668,0.9999934106986268,0,0,1.3741530740276036,1.133618372882936,RXRB;DDB2
KEGG_2021_Human,Coronavirus disease,10/232,0.4487923079133505,0.9999934106986268,0,0,1.08353600749038,0.8681237010312074,PRKCG;CXCL10;MAPK9;RPL3;VWF;IRF3;STAT3;FGG;TMPRSS2;IFNAR1
KEGG_2021_Human,Colorectal cancer,4/86,0.4515440870889137,0.9999934106986268,0,0,1.1731247123791992,0.9327306535274807,GSK3B;MAPK9;TGFA;DDB2
KEGG_2021_Human,Insulin secretion,4/86,0.4515440870889137,0.9999934106986268,0,0,1.1731247123791992,0.9327306535274807,PRKCG;CAMK2D;KCNN2;STX1A
KEGG_2021_Human,Thiamine metabolism,1/15,0.4576078994096485,0.9999934106986268,0,0,1.7174185463659148,1.3425791991410876,AK8
KEGG_2021_Human,Basal cell carcinoma,3/63,0.4633855859578096,0.9999934106986268,0,0,1.202324120603015,0.9248226306652764,GSK3B;WNT11;DDB2
KEGG_2021_Human,RNA transport,8/186,0.4667452267043818,0.9999934106986268,0,0,1.080867625960596,0.8235905675875348,ELAC2;ACIN1;EIF4EBP3;NUP88;TARDBP;EIF4G3;EIF4E;SRRM1
KEGG_2021_Human,Hepatitis B,7/162,0.4708403828258709,0.9999934106986268,0,0,1.08603779732812,0.818042910065117,PRKCG;CCNA2;MAPK9;IRF3;STAT3;IFNAR1;DDB2
KEGG_2021_Human,Leukocyte transendothelial migration,5/114,0.4805806477271515,0.9999934106986268,0,0,1.1029972500173315,0.8082325113234353,PRKCG;CLDN4;CTNND1;CLDN7;PECAM1
KEGG_2021_Human,Measles,6/139,0.4823810668612709,0.9999934106986268,0,0,1.0847547620627862,0.7908088735439222,GSK3B;MAPK9;IRF3;STAT3;CBLB;IFNAR1
KEGG_2021_Human,Bladder cancer,2/41,0.4915792577493139,0.9999934106986268,0,0,1.232956921790046,0.8755622825690677,DAPK2;UPK3A
KEGG_2021_Human,Homologous recombination,2/41,0.4915792577493139,0.9999934106986268,0,0,1.232956921790046,0.8755622825690677,TOP3A;ATM
KEGG_2021_Human,Phenylalanine metabolism,1/17,0.5001115488624014,0.9999934106986268,0,0,1.502584586466165,1.0411770838474956,AOC2
KEGG_2021_Human,Selenocompound metabolism,1/17,0.5001115488624014,0.9999934106986268,0,0,1.502584586466165,1.0411770838474956,TXNRD1
KEGG_2021_Human,Chemokine signaling pathway,8/192,0.5025896346650106,0.9999934106986268,0,0,1.0452921453306216,0.71914142551935,CXCL10;GSK3B;GRK3;STAT3;CCL3;GNB5;FOXO3;CCL17
KEGG_2021_Human,Apoptosis,6/142,0.5031564836907247,0.9999934106986268,0,0,1.0606594466285884,0.7285182434685498,PIDD1;BECN1;MAPK9;ATM;BIRC6;NGF
KEGG_2021_Human,Rheumatoid arthritis,4/93,0.5124156888992849,0.9999934106986268,0,0,1.0804607448236874,0.7224166810301359,ATP6V1G2;PTH;CCL3;ATP6V0E2
KEGG_2021_Human,Neurotrophin signaling pathway,5/119,0.5185648083756904,0.9999934106986268,0,0,1.054343983384153,0.6923774320403262,GSK3B;MAPK9;CAMK2D;FOXO3;NGF
KEGG_2021_Human,Sphingolipid signaling pathway,5/119,0.5185648083756904,0.9999934106986268,0,0,1.054343983384153,0.6923774320403262,PRKCG;MAPK9;SPHK1;PPP2R2D;PLD2
KEGG_2021_Human,Other glycan degradation,1/18,0.5200990354176988,0.9999934106986268,0,0,1.414123544154504,0.9244635156646344,MAN2C1
KEGG_2021_Human,Amphetamine addiction,3/69,0.5241532402008642,0.9999934106986268,0,0,1.092679305619004,0.7058393560188438,PRKCG;CAMK2D;STX1A
KEGG_2021_Human,Central carbon metabolism in cancer,3/70,0.5339114099902385,0.9999934106986268,0,0,1.0763144078601965,0.6754145783863578,HIF1A;HK2;SIRT3
KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,3/70,0.5339114099902385,0.9999934106986268,0,0,1.0763144078601965,0.6754145783863578,MAPK9;ATP6V1G2;ATP6V0E2
KEGG_2021_Human,Influenza A,7/172,0.5342092972161377,0.9999934106986268,0,0,1.0196816651362106,0.6393073403107277,CXCL10;CIITA;IRF3;CALCOCO2;TMPRSS2;PML;IFNAR1
KEGG_2021_Human,Breast cancer,6/147,0.5370873207825707,0.9999934106986268,0,0,1.022779104397521,0.6357539571983417,JAG2;GSK3B;WNT11;CSNK1A1;HES1;DDB2
KEGG_2021_Human,Circadian entrainment,4/97,0.5457776956182102,0.9999934106986268,0,0,1.033772908635964,0.6259945035792033,PRKCG;PER1;CAMK2D;GNB5
KEGG_2021_Human,Fc gamma R-mediated phagocytosis,4/97,0.5457776956182102,0.9999934106986268,0,0,1.033772908635964,0.6259945035792033,PRKCG;SPHK1;PLA2G6;PLD2
KEGG_2021_Human,Phosphatidylinositol signaling system,4/97,0.5457776956182102,0.9999934106986268,0,0,1.033772908635964,0.6259945035792033,PRKCG;CDIPT;PLCD3;IP6K2
KEGG_2021_Human,Aldosterone synthesis and secretion,4/98,0.553932064408709,0.9999934106986268,0,0,1.0227217984745085,0.6041352940794169,PRKCG;NR4A2;CAMK2D;PDE2A
KEGG_2021_Human,Focal adhesion,8/201,0.554847725567879,0.9999934106986268,0,0,0.9960763249772374,0.5867502850538516,PRKCG;GSK3B;MAPK9;VWF;COL4A4;LAMC2;PPP1R12C;MYLK4
KEGG_2021_Human,Steroid biosynthesis,1/20,0.5577111886317847,0.9999934106986268,0,0,1.2651365255243372,0.7387309717879154,SQLE
KEGG_2021_Human,PPAR signaling pathway,3/74,0.5717769975569119,0.9999934106986268,0,0,1.01546464717956,0.5676510621178839,RXRB;HMGCS2;SORBS1
KEGG_2021_Human,"Valine, leucine and isoleucine degradation",2/48,0.5768067530592816,0.9999934106986268,0,0,1.0449511756041678,0.5749822790916536,ACAD8;HMGCS2
KEGG_2021_Human,Melanogenesis,4/101,0.5779169729317595,0.9999934106986268,0,0,0.9909356156389808,0.5433548369208568,PRKCG;GSK3B;CAMK2D;WNT11
KEGG_2021_Human,mTOR signaling pathway,6/154,0.5828291198166762,0.9999934106986268,0,0,0.9740465560137692,0.5258499820742446,PRKCG;GSK3B;FLCN;ATP6V1G2;WNT11;EIF4E
KEGG_2021_Human,Amoebiasis,4/102,0.5857469049881677,0.9999934106986268,0,0,0.9807726864330638,0.524583420592994,PRKCG;ARG2;COL4A4;LAMC2
KEGG_2021_Human,Gastric acid secretion,3/76,0.5899783896886834,0.9999934106986268,0,0,0.987540441935706,0.521094843240238,PRKCG;CAMK2D;MYLK4
KEGG_2021_Human,Axon guidance,7/182,0.5943511231268264,0.9999934106986268,0,0,0.9609090909090908,0.4999466035493316,SEMA6B;GSK3B;CAMK2D;RGS3;PLXNA2;SEMA3F;RHOD
KEGG_2021_Human,Cholesterol metabolism,2/50,0.5991581769823974,0.9999934106986268,0,0,1.001306984525303,0.5128991235310237,OSBPL5;PCSK9
KEGG_2021_Human,N-Glycan biosynthesis,2/50,0.5991581769823974,0.9999934106986268,0,0,1.001306984525303,0.5128991235310237,B4GALT3;DPM2
KEGG_2021_Human,C-type lectin receptor signaling pathway,4/104,0.6011502898680153,0.9999934106986268,0,0,0.9610566037735848,0.4890916135505842,MAPK9;BCL3;CBLB;CCL17
KEGG_2021_Human,Antigen processing and presentation,3/78,0.607673674026085,0.9999934106986268,0,0,0.9611055276381908,0.4787432533951781,CIITA;NFYA;PSME2
KEGG_2021_Human,RNA degradation,3/79,0.6163283179679172,0.9999934106986268,0,0,0.9484098122189896,0.4590070881492276,ZCCHC7;CNOT1;CNOT2
KEGG_2021_Human,Vitamin digestion and absorption,1/24,0.6243323646673151,0.9999934106986268,0,0,1.0448948458101777,0.4922211402423752,PLB1
KEGG_2021_Human,Insulin resistance,4/108,0.6308972356988203,0.9999934106986268,0,0,0.9238993710691824,0.4255594042388472,GSK3B;MAPK9;NR1H2;STAT3
KEGG_2021_Human,Glycosaminoglycan biosynthesis,2/53,0.6309978851119618,0.9999934106986268,0,0,0.942258961300957,0.4338657469901501,B4GALT3;B4GALT4
KEGG_2021_Human,Endocrine and other factor-regulated calcium reabsorption,2/53,0.6309978851119618,0.9999934106986268,0,0,0.942258961300957,0.4338657469901501,PRKCG;PTH
KEGG_2021_Human,Apelin signaling pathway,5/137,0.6437907179073241,0.9999934106986268,0,0,0.9097110907564308,0.4006200055679708,BECN1;SPHK1;NRF1;GNB5;MYLK4
KEGG_2021_Human,Folate biosynthesis,1/26,0.6537838839037663,0.9999934106986268,0,0,0.961203007518797,0.4084905497401835,FPGS
KEGG_2021_Human,Maturity onset diabetes of the young,1/26,0.6537838839037663,0.9999934106986268,0,0,0.961203007518797,0.4084905497401835,HES1
KEGG_2021_Human,Toxoplasmosis,4/112,0.6591815107119737,0.9999934106986268,0,0,0.8894945259725134,0.3707024909669513,MAPK9;CIITA;STAT3;LAMC2
KEGG_2021_Human,PI3K-Akt signaling pathway,13/354,0.6614673184225724,0.9999934106986268,0,0,0.9147620007014244,0.3780662883934489,GSK3B;ANGPT4;VWF;TGFA;LAMC2;FOXO3;NGF;IL7;COL4A4;PPP2R2D;GNB5;EIF4E;IFNAR1
KEGG_2021_Human,Complement and coagulation cascades,3/85,0.6655039606926277,0.9999934106986268,0,0,0.8787382032111778,0.3578315898047601,VWF;FGG;PLAUR
KEGG_2021_Human,Serotonergic synapse,4/113,0.6660190315943877,0.9999934106986268,0,0,0.8812878656742253,0.3581880252399693,PRKCG;CACNA1A;KCNN2;GNB5
KEGG_2021_Human,Cholinergic synapse,4/113,0.6660190315943877,0.9999934106986268,0,0,0.8812878656742253,0.3581880252399693,PRKCG;CAMK2D;CACNA1A;GNB5
KEGG_2021_Human,Glutathione metabolism,2/57,0.6703336977721537,0.9999934106986268,0,0,0.8735485342762632,0.3494016232042273,ODC1;PRDX6
KEGG_2021_Human,Pathogenic Escherichia coli infection,7/197,0.6764853190674994,0.9999934106986268,0,0,0.8843500797448166,0.3456433938479164,MAPK9;CLDN4;SEC24A;CLDN7;BAIAP2;SEC24C;CYTH1
KEGG_2021_Human,Endocytosis,9/252,0.6808605397540907,0.9999934106986268,0,0,0.8887951242381622,0.3416508737370683,EPN3;SH3GLB2;GRK3;SMURF1;CBLB;RAB11FIP2;CYTH1;PML;PLD2
KEGG_2021_Human,ECM-receptor interaction,3/88,0.6883075584434903,0.9999934106986268,0,0,0.8475908956547443,0.3165917345987183,VWF;COL4A4;LAMC2
KEGG_2021_Human,VEGF signaling pathway,2/59,0.6886932519752479,0.9999934106986268,0,0,0.8428096590283739,0.314333712841874,PRKCG;SPHK1
KEGG_2021_Human,GABAergic synapse,3/89,0.6956447170221897,0.9999934106986268,0,0,0.8376913637957228,0.3040117774345208,PRKCG;CACNA1A;GNB5
KEGG_2021_Human,Long-term depression,2/60,0.6975532181542408,0.9999934106986268,0,0,0.8282351923160126,0.2983108277061464,PRKCG;CACNA1A
KEGG_2021_Human,Bile secretion,3/90,0.7028504783613917,0.9999934106986268,0,0,0.8280194073817363,0.2919688345568563,AQP9;AQP4;KCNN2
KEGG_2021_Human,"Growth hormone synthesis, secretion and action",4/119,0.7050556058889724,0.9999934106986268,0,0,0.835045118949959,0.2918304038495595,PRKCG;GSK3B;MAPK9;STAT3
KEGG_2021_Human,beta-Alanine metabolism,1/30,0.7059484644813765,0.9999934106986268,0,0,0.8284504364359174,0.2884772454897016,AOC2
KEGG_2021_Human,Arachidonic acid metabolism,2/61,0.7062032186199638,0.9999934106986268,0,0,0.8141547753227144,0.2832055605421494,PLA2G6;PLB1
KEGG_2021_Human,Retrograde endocannabinoid signaling,5/148,0.7094169215516287,0.9999934106986268,0,0,0.8392489122967712,0.2881241248882198,PRKCG;MAPK9;CACNA1A;NDUFV3;GNB5
KEGG_2021_Human,Pathways of neurodegeneration,17/475,0.7136223435531279,0.9999934106986268,0,0,0.889643060565787,0.3001668027242163,PRKCG;BECN1;GSK3B;CAMK2D;CSNK1A1;DNAH9;SNCAIP;MAPK9;PSMC5;WNT11;PSMD4;PSMC3;MFN1;SMCR8;NDUFV3;TARDBP;STX1A
KEGG_2021_Human,Gastric cancer,5/149,0.7149389826489055,0.9999934106986268,0,0,0.8333770640917996,0.2796464066112029,RXRB;GSK3B;WNT11;CSNK1A1;DDB2
KEGG_2021_Human,Proteoglycans in cancer,7/205,0.7157478829449996,0.9999934106986268,0,0,0.8482616569737782,0.2836818495462495,PRKCG;CAMK2D;WNT11;STAT3;PLAUR;HIF1A;PPP1R12C
KEGG_2021_Human,Th1 and Th2 cell differentiation,3/92,0.7168700305797729,0.9999934106986268,0,0,0.8093275365592005,0.2693933491103077,JAG2;MAPK9;IL12RB1
KEGG_2021_Human,Galactose metabolism,1/31,0.7177134150648125,0.9999934106986268,0,0,0.8007936507936508,0.2656111883915782,HK2
KEGG_2021_Human,Cytosolic DNA-sensing pathway,2/63,0.7228838980831014,0.9999934106986268,0,0,0.7873789003846391,0.2555096918290494,CXCL10;IRF3
KEGG_2021_Human,GnRH signaling pathway,3/93,0.723685167749875,0.9999934106986268,0,0,0.8002931323283082,0.258813864529351,MAPK9;CAMK2D;PLD2
KEGG_2021_Human,TGF-beta signaling pathway,3/94,0.7303715890621244,0.9999934106986268,0,0,0.7914572864321608,0.2486773421976614,SMURF1;ID2;NODAL
KEGG_2021_Human,GnRH secretion,2/64,0.7309201669184922,0.9999934106986268,0,0,0.7746387663415226,0.2428113238185528,PRKCG;KCNN2
KEGG_2021_Human,Inflammatory bowel disease,2/65,0.7387576223593729,0.9999934106986268,0,0,0.7623030809981877,0.2308142375081537,STAT3;IL12RB1
KEGG_2021_Human,Base excision repair,1/33,0.7398516287670887,0.9999934106986268,0,0,0.7506657268170426,0.2261797981426067,LIG3
KEGG_2021_Human,Prostate cancer,3/97,0.7496677650475063,0.9999934106986268,0,0,0.7660777290708863,0.2207262610085558,GSK3B;TGFA;TMPRSS2
KEGG_2021_Human,Pentose and glucuronate interconversions,1/34,0.7502616748104639,0.9999934106986268,0,0,0.7278803068276752,0.2091442022024266,SORD
KEGG_2021_Human,Cellular senescence,5/156,0.7515069983764583,0.9999934106986268,0,0,0.7944517657263916,0.2269548153516609,CCNA2;HUS1;ATM;MYBL2;FOXO3
KEGG_2021_Human,Osteoclast differentiation,4/127,0.751800417633448,0.9999934106986268,0,0,0.7804059927391727,0.2226376494177477,MAPK9;JUND;IFNAR1;FOSL2
KEGG_2021_Human,Long-term potentiation,2/67,0.7538483130967765,0.9999934106986268,0,0,0.7387703889585947,0.2087499955865674,PRKCG;CAMK2D
KEGG_2021_Human,Lysosome,4/128,0.7572227455615743,0.9999934106986268,0,0,0.7740718198417529,0.2152676864399974,LAPTM4B;AP3M1;ENTPD4;CTSE
KEGG_2021_Human,Lipid and atherosclerosis,7/215,0.7601262483839443,0.9999934106986268,0,0,0.8070549242424242,0.2213515538775142,RXRB;GSK3B;MAPK9;CAMK2D;IRF3;STAT3;CCL3
KEGG_2021_Human,Relaxin signaling pathway,4/129,0.7625530770310855,0.9999934106986268,0,0,0.7678389937106919,0.2081482236289189,MAPK9;COL4A4;GNB5;INSL5
KEGG_2021_Human,Purine metabolism,4/129,0.7625530770310855,0.9999934106986268,0,0,0.7678389937106919,0.2081482236289189,ENTPD4;IMPDH1;PDE2A;AK8
KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,3/100,0.7678415418599207,0.9999934106986268,0,0,0.7422680412371134,0.1960863534376844,CXCL10;CCL3;CCL17
KEGG_2021_Human,Starch and sucrose metabolism,1/36,0.769850169583299,0.9999934106986268,0,0,0.6862155388471178,0.1794861026699729,HK2
KEGG_2021_Human,Tyrosine metabolism,1/36,0.769850169583299,0.9999934106986268,0,0,0.6862155388471178,0.1794861026699729,AOC2
KEGG_2021_Human,DNA replication,1/36,0.769850169583299,0.9999934106986268,0,0,0.6862155388471178,0.1794861026699729,RNASEH2A
KEGG_2021_Human,African trypanosomiasis,1/37,0.7790611749158508,0.9999934106986268,0,0,0.667119186856029,0.1665567828631871,PRKCG
KEGG_2021_Human,Chagas disease,3/102,0.7793497447114509,0.9999934106986268,0,0,0.7271965890056342,0.1812867409831621,MAPK9;PPP2R2D;CCL3
KEGG_2021_Human,Parkinson disease,8/249,0.7821849654937233,0.9999934106986268,0,0,0.7956733165120049,0.195468319577538,MAPK9;PSMC5;CAMK2D;PSMD4;PSMC3;MFN1;NDUFV3;SNCAIP
KEGG_2021_Human,Huntington disease,10/306,0.784140886816638,0.9999934106986268,0,0,0.809483437810434,0.1968393128283216,BECN1;MAPK9;PSMC5;PSMD4;PSMC3;DNAH9;NRF1;NDUFV3;STX1A;RCOR1
KEGG_2021_Human,Primary immunodeficiency,1/38,0.7879039791588477,0.9999934106986268,0,0,0.6490550701077017,0.1547211312750138,CIITA
KEGG_2021_Human,T cell receptor signaling pathway,3/104,0.7903841361022981,0.9999934106986268,0,0,0.7127220259714414,0.1676580235194499,GSK3B;MAPK9;CBLB
KEGG_2021_Human,Inositol phosphate metabolism,2/73,0.7946775090744848,0.9999934106986268,0,0,0.676127025641932,0.1553867663105761,CDIPT;PLCD3
KEGG_2021_Human,Various types of N-glycan biosynthesis,1/39,0.7963932831099112,0.9999934106986268,0,0,0.6319416963461285,0.1438691995100741,B4GALT3
KEGG_2021_Human,Yersinia infection,4/137,0.8019605684867752,0.9999934106986268,0,0,0.7213505461767626,0.159199063857085,GSK3B;MAPK9;IRF3;BAIAP2
KEGG_2021_Human,"Glycine, serine and threonine metabolism",1/40,0.8045432012484874,0.9999934106986268,0,0,0.6157059314954052,0.1339041043270966,AOC2
KEGG_2021_Human,Nicotine addiction,1/40,0.8045432012484874,0.9999934106986268,0,0,0.6157059314954052,0.1339041043270966,CACNA1A
KEGG_2021_Human,Glucagon signaling pathway,3/107,0.8060721563312534,0.9999934106986268,0,0,0.6920540201005025,0.1491944011790602,CAMK2D;PHKG1;PHKG2
KEGG_2021_Human,Ferroptosis,1/41,0.8123672852794788,0.9999934106986268,0,0,0.600281954887218,0.1247402225809026,CP
KEGG_2021_Human,Chronic myeloid leukemia,2/76,0.8127572109737222,0.9999934106986268,0,0,0.648614737698803,0.1344726543649976,CTBP1;DDB2
KEGG_2021_Human,Pertussis,2/76,0.8127572109737222,0.9999934106986268,0,0,0.648614737698803,0.1344726543649976,MAPK9;IRF3
KEGG_2021_Human,Viral carcinogenesis,6/203,0.8255415437479375,0.9999934106986268,0,0,0.7298890674109114,0.1399311871532383,CCNA2;KAT2A;HDAC3;IRF3;STAT3;SCRIB
KEGG_2021_Human,Porphyrin and chlorophyll metabolism,1/43,0.8270894765285018,0.9999934106986268,0,0,0.5716374269005848,0.1085210185954894,CP
KEGG_2021_Human,TNF signaling pathway,3/112,0.8300165596826128,0.9999934106986268,0,0,0.6601355400857498,0.1229896062201675,CXCL10;MAPK9;BCL3
KEGG_2021_Human,Vasopressin-regulated water reabsorption,1/44,0.8340120700404822,0.9999934106986268,0,0,0.5583143906277321,0.101338195802455,AQP4
KEGG_2021_Human,Cytokine-cytokine receptor interaction,9/295,0.8377443067623376,0.9999934106986268,0,0,0.753452243958573,0.133392954568356,CXCL10;IL7;LEPR;CCL3;IL12RB1;NGF;CCL17;NODAL;IFNAR1
KEGG_2021_Human,Basal transcription factors,1/45,0.8406578423197996,0.9999934106986268,0,0,0.5455969469127364,0.0946995610761307,ERCC2
KEGG_2021_Human,ABC transporters,1/45,0.8406578423197996,0.9999934106986268,0,0,0.5455969469127364,0.0946995610761307,ABCA7
KEGG_2021_Human,Peroxisome,2/82,0.8447010108857417,0.9999934106986268,0,0,0.5997804265997491,0.1012264705438964,ACOT8;PEX1
KEGG_2021_Human,Cell adhesion molecules,4/148,0.847308776211788,0.9999934106986268,0,0,0.6658630328441649,0.1103269111498068,CLDN4;CLDN7;PECAM1;SIGLEC1
KEGG_2021_Human,Tuberculosis,5/180,0.8503435281962289,0.9999934106986268,0,0,0.6846347607052897,0.1109894686058068,MAPK9;CIITA;CAMK2D;NFYA;SPHK1
KEGG_2021_Human,Other types of O-glycan biosynthesis,1/47,0.8531627069511415,0.9999934106986268,0,0,0.5218208564890487,0.0828677626601128,B4GALT3
KEGG_2021_Human,Carbohydrate digestion and absorption,1/47,0.8531627069511415,0.9999934106986268,0,0,0.5218208564890487,0.0828677626601128,HK2
KEGG_2021_Human,NOD-like receptor signaling pathway,5/181,0.853636404901797,0.9999934106986268,0,0,0.6807090107625372,0.1077221541458751,MAPK9;IRF3;MFN1;TXNIP;IFNAR1
KEGG_2021_Human,Human immunodeficiency virus 1 infection,6/212,0.8548230099623962,0.9999934106986268,0,0,0.6976701477736016,0.1094371235850197,PRKCG;MAPK9;IRF3;ATM;GNB5;RNF7
KEGG_2021_Human,Sphingolipid metabolism,1/49,0.864687332254273,0.9999934106986268,0,0,0.5000261069340016,0.07269744711507,SPHK1
KEGG_2021_Human,Cardiac muscle contraction,2/87,0.8674508597465325,0.9999934106986268,0,0,0.5643516126651413,0.0802487758895647,CACNB2;TRDN
KEGG_2021_Human,Malaria,1/50,0.8701062798993108,0.9999934106986268,0,0,0.4897959183673469,0.068150161954641,PECAM1
KEGG_2021_Human,Non-alcoholic fatty liver disease,4/155,0.8713472330748852,0.9999934106986268,0,0,0.6347619642634013,0.0874160670173904,GSK3B;MAPK9;LEPR;NDUFV3
KEGG_2021_Human,Cushing syndrome,4/155,0.8713472330748852,0.9999934106986268,0,0,0.6347619642634013,0.0874160670173904,GSK3B;CAMK2D;WNT11;ASH2L
KEGG_2021_Human,Gap junction,2/88,0.8716169725990963,0.9999934106986268,0,0,0.5577602054214934,0.0766391543510701,PRKCG;CSNK1D
KEGG_2021_Human,MicroRNAs in cancer,9/310,0.875608418694951,0.9999934106986268,0,0,0.7153370621136297,0.0950227275875655,PRKCG;ST14;STAT3;PIM1;ATM;MDM4;DICER1;BCL2L2;FOXP1
KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,2/89,0.8756623012835812,0.9999934106986268,0,0,0.5513203247811477,0.0732014255636129,STAT3;HIF1A
KEGG_2021_Human,Platelet activation,3/124,0.8773381259818648,0.9999934106986268,0,0,0.5942937829644088,0.0777709558749354,VWF;FGG;MYLK4
KEGG_2021_Human,Cell cycle,3/124,0.8773381259818648,0.9999934106986268,0,0,0.5942937829644088,0.0777709558749354,CCNA2;GSK3B;ATM
KEGG_2021_Human,Neutrophil extracellular trap formation,5/189,0.8778622387493691,0.9999934106986268,0,0,0.6508391742415945,0.0847819562729535,PRKCG;HDAC3;VWF;AQP9;FGG
KEGG_2021_Human,Ribosome,4/158,0.880608366833203,0.9999934106986268,0,0,0.6222984562607204,0.0791204473192603,MRPS17;MRPL4;RPL3;MRPL23
KEGG_2021_Human,Necroptosis,4/159,0.8835642114041959,0.9999934106986268,0,0,0.6182511665652262,0.0765341226963981,MAPK9;CAMK2D;STAT3;IFNAR1
KEGG_2021_Human,Human cytomegalovirus infection,6/225,0.8898825690866441,0.9999934106986268,0,0,0.6558068026740832,0.0765102054792333,PRKCG;GSK3B;IRF3;STAT3;CCL3;GNB5
KEGG_2021_Human,Pyrimidine metabolism,1/56,0.8983593227856012,0.9999934106986268,0,0,0.4362269309637731,0.0467570507660091,ENTPD4
KEGG_2021_Human,Oxidative phosphorylation,3/133,0.9047575058847244,0.9999934106986268,0,0,0.5528894472361809,0.0553377761881282,ATP6V1G2;NDUFV3;ATP6V0E2
KEGG_2021_Human,Hematopoietic cell lineage,2/99,0.9101061762242926,0.9999934106986268,0,0,0.4942244758048869,0.0465529847753326,IL7;DNTT
KEGG_2021_Human,Diabetic cardiomyopathy,5/203,0.9120675569148752,0.9999934106986268,0,0,0.604374984097906,0.0556274085087565,PRKCG;GSK3B;MAPK9;CAMK2D;NDUFV3
KEGG_2021_Human,Progesterone-mediated oocyte maturation,2/100,0.9130095257554844,0.9999934106986268,0,0,0.4891557626814841,0.0445175596729406,CCNA2;MAPK9
KEGG_2021_Human,Viral myocarditis,1/60,0.9136950002397894,0.9999934106986268,0,0,0.4065672656216813,0.0366961356822014,EIF4G3
KEGG_2021_Human,Steroid hormone biosynthesis,1/61,0.9171531822651248,0.9999934106986268,0,0,0.3997702589807853,0.0345724412170898,CYP7B1
KEGG_2021_Human,Pancreatic secretion,2/102,0.9185542369009826,0.9999934106986268,0,0,0.4793224592220828,0.0407205167670339,PRKCG;TPCN2
KEGG_2021_Human,Amyotrophic lateral sclerosis,10/364,0.9201064150383248,0.9999934106986268,0,0,0.6747796323745283,0.0561861651790017,BECN1;PSMC5;PSMD4;PSMC3;NUP88;SMCR8;DNAH9;NDUFV3;TARDBP;SRSF7
KEGG_2021_Human,NF-kappa B signaling pathway,2/104,0.9237653540889263,0.9999934106986268,0,0,0.4698747755061874,0.0372597471793345,PIDD1;ATM
KEGG_2021_Human,Aminoacyl-tRNA biosynthesis,1/66,0.9324754191833444,0.9999934106986268,0,0,0.368922305764411,0.0257922762513341,PARS2
KEGG_2021_Human,Glycolysis / Gluconeogenesis,1/67,0.935181876546179,0.9999934106986268,0,0,0.3633135869977975,0.0243471869079768,HK2
KEGG_2021_Human,Salmonella infection,6/249,0.935913264462748,0.9999934106986268,0,0,0.5902884809988636,0.0390962658626123,MAPK9;AHNAK;EXOC5;VPS39;CYTH1;VPS16
KEGG_2021_Human,Fc epsilon RI signaling pathway,1/68,0.9377799826648616,0.9999934106986268,0,0,0.3578722926719784,0.0229896865740361,MAPK9
KEGG_2021_Human,Phospholipase D signaling pathway,3/148,0.93837801199835,0.9999934106986268,0,0,0.4953041067405995,0.0315025365019907,SPHK1;CYTH1;PLD2
KEGG_2021_Human,Human T-cell leukemia virus 1 infection,5/219,0.9406099929739216,0.9999934106986268,0,0,0.5587172485227995,0.0342084052506889,CCNA2;MAPK9;KAT2A;GPS2;ATM
KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,3/150,0.9419219338134508,0.9999934106986268,0,0,0.4885139985642498,0.0292291997716633,CACNB2;CAMK2D;PPP2R2D
KEGG_2021_Human,Melanoma,1/72,0.9471729909748456,0.9999934106986268,0,0,0.3376398743337216,0.0183249077998079,DDB2
KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,1/77,0.9569479650562728,0.9999934106986268,0,0,0.3153442817570241,0.0138771230798582,CACNB2
KEGG_2021_Human,Alzheimer disease,9/369,0.9614593083103258,0.9999934106986268,0,0,0.5962341772151899,0.0234338132712795,GSK3B;BECN1;MAPK9;PSMC5;WNT11;PSMD4;PSMC3;CSNK1A1;NDUFV3
KEGG_2021_Human,B cell receptor signaling pathway,1/81,0.9634499331845984,0.9999934106986268,0,0,0.2995144110275689,0.0111523460012278,GSK3B
KEGG_2021_Human,Prion disease,6/273,0.9640038767815202,0.9999934106986268,0,0,0.5365487340068295,0.0196698566409267,GSK3B;MAPK9;PSMC5;PSMD4;PSMC3;NDUFV3
KEGG_2021_Human,cGMP-PKG signaling pathway,3/167,0.9652419738723051,0.9999934106986268,0,0,0.4374846794950361,0.0154766588049588,NPPB;PDE2A;MYLK4
KEGG_2021_Human,Natural killer cell mediated cytotoxicity,2/131,0.9694553106272548,0.9999934106986268,0,0,0.3710036668514682,0.0115088678866967,PRKCG;IFNAR1
KEGG_2021_Human,Taste transduction,1/86,0.9702157306456636,0.9999934106986268,0,0,0.2818222025652366,0.0085214098840636,CACNA1A
KEGG_2021_Human,Rap1 signaling pathway,4/210,0.9704956734569772,0.9999934106986268,0,0,0.4639433351651706,0.0138943301621205,PRKCG;ANGPT4;CTNND1;NGF
KEGG_2021_Human,Hypertrophic cardiomyopathy,1/90,0.974715714144807,0.9999934106986268,0,0,0.2690997155810875,0.0068914891819434,CACNB2
KEGG_2021_Human,Estrogen signaling pathway,2/137,0.9751913413255062,0.9999934106986268,0,0,0.3544030856452437,0.0089031653708139,TGFA;FKBP5
KEGG_2021_Human,Regulation of actin cytoskeleton,4/218,0.976546956799074,0.9999934106986268,0,0,0.4464115676247575,0.0105944370750387,BAIAP2;PPP1R12C;ARHGEF6;MYLK4
KEGG_2021_Human,Fluid shear stress and atherosclerosis,2/139,0.9768607420361768,0.9999934106986268,0,0,0.3491926842447499,0.0081750104799263,MAPK9;PECAM1
KEGG_2021_Human,Salivary secretion,1/93,0.977639077929292,0.9999934106986268,0,0,0.2602838618284842,0.0058862461434768,PRKCG
KEGG_2021_Human,Staphylococcus aureus infection,1/95,0.9793978956734364,0.9999934106986268,0,0,0.2547192449208126,0.0053025639580157,FGG
KEGG_2021_Human,Dilated cardiomyopathy,1/96,0.980224781455055,0.9999934106986268,0,0,0.2520247988392032,0.0050337832425452,CACNB2
KEGG_2021_Human,Alcoholism,3/186,0.9807776390349934,0.9999934106986268,0,0,0.3916714721146717,0.0076021524357893,HDAC3;GNB5;CAMKK2
KEGG_2021_Human,Thermogenesis,4/232,0.9844245427626542,0.9999934106986268,0,0,0.4186913825444113,0.0065726294982655,NPPB;NDUFAF3;NDUFV3;SMARCA2
KEGG_2021_Human,Protein digestion and absorption,1/103,0.985155460770201,0.9999934106986268,0,0,0.2346429799990171,0.0035092786589594,COL4A4
KEGG_2021_Human,Phagosome,2/152,0.9853413805609386,0.9999934106986268,0,0,0.3187118360518611,0.0047064554838204,ATP6V1G2;ATP6V0E2
KEGG_2021_Human,Chemical carcinogenesis,4/239,0.987349979053949,0.9999934106986268,0,0,0.4060698514652749,0.0051695590184576,PRKCG;RXRB;STAT3;CACNA1A
KEGG_2021_Human,Drug metabolism,1/108,0.9879058399961548,0.9999934106986268,0,0,0.2236197971564425,0.00272098096472,IMPDH1
KEGG_2021_Human,cAMP signaling pathway,3/216,0.992697969766784,0.9999934106986268,0,0,0.3359756529124496,0.002462305269854,MAPK9;CAMK2D;PLD2
KEGG_2021_Human,Oocyte meiosis,1/129,0.9948876183611896,0.9999934106986268,0,0,0.1867265820802005,0.0009570660831111032,CAMK2D
KEGG_2021_Human,Neuroactive ligand-receptor interaction,5/341,0.9980620034051076,0.9999934106986268,0,0,0.353563182199832,0.0006858690640135336,P2RX4;PTH;NPFF;LEPR;INSL5
KEGG_2021_Human,Herpes simplex virus 1 infection,5/498,0.999983867917646,0.9999934106986268,0,0,0.2389626049325315,3.854995516950884e-06,IRF3;SRSF5;SRSF7;PML;IFNAR1
KEGG_2021_Human,Olfactory transduction,3/440,0.9999934106986268,0.9999934106986268,0,0,0.1618274438554327,1.0663333112006e-06,GRK3;CAMK2D;PDE2A
